Journal of Clinical Immunology

, Volume 9, Issue 5, pp 415–420 | Cite as

Spontaneous production of bone-resorbing lymphokines by B cells in patients with systemic lupus erythematosus

  • Yoshiya Tanaka
  • Kenichi Watanabe
  • Masahito Suzuki
  • Kazuyoshi Saito
  • Susumu Oda
  • Hidero Suzuki
  • Sumiya Eto
  • Uki Yamashita
Original Articles

Abstract

The culture supernatant of B cells from patients with active systemic lupus erythematosus (SLE) who had never been treated with corticosteroids had bone-resorbing activity (BRA) which stimulated the45Ca release from prelabeled murine fetal bones. Then we studied the characteristics and the relationship of this BRA with several lymphokines previously reported. The BRA was eluted as three peaks at approximately 17,000, 35,000, and 80,000 daltons by Sephacryl S-200 column chromatography. Recombinant (r)IL 1α, rIL 1β, and rTNF possessed BRA, but rIL 4 and rIL 6 did not. Furthermore, the BRA from SLE B cells was absorbed with anti-IL 1α antibody but not with anti-IL 1β and anti-TNF antibody. Therefore, the fact that SLE B cells produce BRA which corresponds to IL 1α and IL 1α produced by B cells might be one of the causes of bone destruction in SLE patients.

Key words

Systemic lupus erythematosus (SLE) B cell bone-resorbing activity (BRA) interleukin 1 (IL 1) 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Horton JE, Raisz LG, Simmons HA, Oppenheim JJ, Mergenhagen SE: Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes. Science 177:793–795, 1972Google Scholar
  2. 2.
    Smith HR, Steinberg AD: Autoimmunity-A perspective. Annu Rev Immunol 1:175–210, 1983Google Scholar
  3. 3.
    Steinberg AD, Raveche ES, Laskin CA, Smith HR, Sontoro T, Miller ML, Plotz PH: Systemic lupus erythematosus: Insights from animal model. Ann Intern Med 100:714–727, 1984Google Scholar
  4. 4.
    Dubois LE, Cozen L: A vascular (aseptic) bone necrosis associated with systemic lupus erythematosus. JAMA 174:966–971, 1960Google Scholar
  5. 5.
    Smith SE, Sweet DE, Brunner CM, Davis JS: A vascular: necrosis in SLE: An apparent predilection for young patients. Ann Rheum Dis 35:227–232, 1976Google Scholar
  6. 6.
    Siemsen JK, Brook J, Meister L: Lupus erythematosus and avascular bone necrosis: A clinical study of three cases and review of the literature. Arth Rheum 5:492–501, 1962Google Scholar
  7. 7.
    Nilsen KH: Systemic lupus erythematosus and avascular bone necrosis. NZ Med J 85:472–475, 1977Google Scholar
  8. 8.
    Wilde AH, Mankin HJ, Rodman GP: Avascular necrosis of the femoral head in scleroderma. Arch Rheum 13:445–447, 1970Google Scholar
  9. 9.
    Zizic TM, Hungerford DS, Stevens MB: Ischemic bone necrosis in systemic lupus erythematosus. I. The early diagnosis of ischemic necrosis of bone. Medicine 59:134–142, 1980Google Scholar
  10. 10.
    Klipper AR, Stevens MB, Zizic TM, Hungerford DS: Ischemic necrosis of bone in systemic lupus erythematosus. Medicine 55:251–257, 1976Google Scholar
  11. 11.
    Labowitz R, Schumacher HR Jr: Articular manifestations of systemic lupus erythematosus. Ann Intern Med 74:911–921, 1971Google Scholar
  12. 12.
    Brookes M, Helal B: Primary osteoarthritis, venous engorgement and osteogenesis. J Bone Joint Surgery 50B:493–504, 1968Google Scholar
  13. 13.
    Tanaka Y, Shirakawa F, Ota U, Suzuki H, Eto S, Yamashita U: Mechanism of spontaneous activation of B cells in patients with systemic lupus erythematosus: Analysis with anti-class II antibody. J Immunol 140:761–767, 1988Google Scholar
  14. 14.
    Tanaka Y, Saito K, Shirakawa F, Suzuki H, Eto S, Yamashita U: Production of B cell stimulating factors by B cells in patients with systemic lupus erythematosus. J Immunol 141:3043–3049, 1988Google Scholar
  15. 15.
    Gowen M, Wood DD, Ihrie EJ, McGuire MKB, Russell RGG: An interleukin I like factor stimulates bone resorptionin vitro. Nature 306:378–380, 1983Google Scholar
  16. 16.
    Stashenko P, Dewhirst FE, Peros WJ, Kent RL, Ago JM: Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J Immunol 138:1464–1468, 1987Google Scholar
  17. 17.
    Dewhrist FE, Stashenko PP, Mole JE, Tsurumachi T: Purification and partial sequence of human osteoclast-activating factor: Identity with interleukin 1β. J Immunol 135:2562–2568, 1985Google Scholar
  18. 18.
    Sato K, Mimura H, Han DC, Kakiuchi T, Ueyama Y, Ohkawa H, Okabe T, Kondo Y, Ohsawa N, Tsushima T, Shizume K: Production of bone-resorbing activity and colony-stimulating activityin vivo andin vitro by a human squamous cell carcinoma associated with hypercalcemia and leukocytosis. J Clin Invest 78:145–154, 1986Google Scholar
  19. 19.
    Tan EM, Cohen AS, Fries J, Masi AT, McShane OJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria of the classification of systemic lupus erythematosus. Arth Rheum 25:1271–1277, 1982Google Scholar
  20. 20.
    Budman DR, Merchant EB, Steinberg AD, Doft B, Gershwin ME, Lizzio E, Reeves JP: Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE. Arth Rheum 20:829–833, 1977Google Scholar
  21. 21.
    Furutani Y, Notake M, Yamayoshi M, Yamagishi R, Fukui T, Yamada M, Nakamura S: Cloning for and characterization of the cDNA for human and rabbit interleukin 1 precursor. Nucleic Acids Res 13:5869–5882, 1985Google Scholar
  22. 22.
    Nishida T, Nishino N, Takano M, Kawai K, Bando K, Masui Y, Nakai S, Hirai Y: cDNA cloning of IL 1α and IL 1β from mRNA of U937 cell line. Biochem Biophys Res Commun 143:345–352, 1987Google Scholar
  23. 23.
    Severinson E, Naito T, Tokumoto H, Fukushima D, Hirano A, Hama K, Honjo T: Interleukin 4 (IgG1 induction factor): A multifunctional lymphokine acting also on T cells. Eur J Immunol 17:67–72, 1987Google Scholar
  24. 24.
    Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Iwamatsu A, Tsunasawa S, Sakiyama F, Matsui H, Takahara Y, Taniguchi T, Kishimoto T: Complementary DNA for a novel human interleukin 6 (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324:73–76, 1986Google Scholar
  25. 25.
    Hirano T, Taga T, Yasukawa K, Nakajima K, Nakao N, Takatsuki F, Shimizu M, Murashima A, Tsunasawa S, Sakiyama F, Kishimoto T: Human B cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. Proc Natl Acad Sci USA 84:228–231, 1987Google Scholar
  26. 26.
    Shirai T, Yamaguchi H, Ito H, Todd CW, Wallace RB: Cloning and expression inEscherichia coli of the gene for human tumor necrosis factor. Nature 313:803–806, 1985Google Scholar
  27. 27.
    Niitsu Y, Watanabe N, Sone H, Neda H, Yamaguchi N, Urushizaki I: Mechanism of the cytotoxic effect of tumor necrosis factor. Jpn J Cancer Res (Gann) 76:1193–1197, 1985Google Scholar
  28. 28.
    Yamashita U, Shirakawa F, Nakamura H: Production of interleukin 1 by adult T cell leukemia (ATL) cell lines. J Immunol 138:3284–3289, 1987Google Scholar
  29. 29.
    Shirakawa F, Yamashita U, Tanaka Y, Watanabe K, Sato K, Haratake J, Fujihira T, Oda S, Eto S: Production of bone-resorbing activity corresponding to interleukin-1α by adult T-cell leukemia cells in humans. Cancer Res 48:4264–4287, 1988Google Scholar
  30. 30.
    Raisz LG: Bone resorption in tissue culture: Factors influencing the response to parathyroid hormone. J Clin Invest 44:103–116, 1965Google Scholar
  31. 31.
    Ruff MR, Gifford GE: Purification and physico-chemical characterization of rabbit tumor necrosis factor. J Immunol 125:1671–1677, 1980Google Scholar
  32. 32.
    Yokota T, Otsuka T, Mosmann T, Banchereau J, Defrance T, Blanchard D, de Vries J, Lee F, Arai K: Isolation and characterization of a human interleukin cDNA clone, homologous to mouse BSF-1, which expresses B cell and T cell stimulating activities. Proc Natl Acad Sci USA 83:5894–5898, 1986Google Scholar
  33. 33.
    Chen P, Trummel C, Horton J, Baker JJ, Oppenheim JJ: Production of osteoclast-activating factor by normal human peripheral blood rosetting and nonrosetting lymphocytes. Eur J Immunol 6:732–736, 1976Google Scholar
  34. 34.
    Yoneda T, Mundy GR: Prostaglandins are necessary for osteoclast activating factor production by activated peripheral blood leukocytes. J Exp Med 149:279–283, 1979Google Scholar
  35. 35.
    Luben RA: Purification of a lymphokine: Osteoclast activating factor from human tonsil lymphocytes. Biochem Biophys Res Commun 84:15–22, 1978Google Scholar
  36. 36.
    Mundy GR, Luben RA, Raisz LG, Oppenheim JJ, Buell DN: Bone-resorbing activity in supernatants from lymphoid cell lines. N Engl J Med 290:867–871, 1974Google Scholar
  37. 37.
    Scala G, Kuang YD, Hall RE, Muchmore AV, Oppenheim JJ: Accessory cell function of human B cells. I. Production of both interleukin 1-like activity and an interleukin 1 inhibitory factor by an EBV-transformed human B cell line. J Exp Med 139:1637–1652, 1984Google Scholar
  38. 38.
    Matsushima K, Antonio P, Abe H, Scala G, Ortaldo JR, Oppenheim JJ: Production of interleukin 1 activity by normal human peripheral blood B lymphocytes. J Immunol 135:1132–1136, 1985Google Scholar
  39. 39.
    Gray PW, Glaister D, Chen E, Goeddel DV, Pennica D: Two interleukin 1 gene in the mouse: Cloning and expression of the cDNA for murine interleukin 1β. J Immunol 137:3644–3648, 1986Google Scholar
  40. 40.
    March CJ, Mosley B, Larson A, Carretti DP, Braedt G, Price V, Gillis S, Henney CS, Kronheim SR, Grabstein K, Conlon PJ, Hopp TP, Cosmon D: Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 315:641–647, 1985Google Scholar
  41. 41.
    Shirakawa F, Yamashita U, Suzuki H: Decrease in HLA-DR-positive monocytes in patients with systemic lupus erythematosus (SLE). J Immunol 134:3560–3562, 1985Google Scholar
  42. 42.
    Shirakawa F, Yamashita U, Suzuki H: Reduced function of HLA-DR-positive monocytes in patients with systemic lupus erythematosus (SLE). J Clin Immunol 5:396–403, 1985Google Scholar
  43. 43.
    Sato K, Fujii Y, Kasano K, Saji M, Tsushima T, Shizume K: Stimulation of prostaglandin E2 and bone resorption by recombinant human interleukin 1 alpha in fetal mouse bones. Biochem Biophys Res Commun 138:618–624, 1986Google Scholar

Copyright information

© Plenum Publishing Corporation 1989

Authors and Affiliations

  • Yoshiya Tanaka
    • 1
  • Kenichi Watanabe
    • 1
  • Masahito Suzuki
    • 1
  • Kazuyoshi Saito
    • 1
  • Susumu Oda
    • 1
  • Hidero Suzuki
    • 1
  • Sumiya Eto
    • 1
  • Uki Yamashita
    • 2
  1. 1.First Department of Internal Medicine, School of MedicineUniversity of Occupational and Environmental HealthYahatanishiku, KitakyushuJapan
  2. 2.Department of Immunology, School of MedicineUniversity of Occupational and Environmental Health, School of MedicineYahatanishiku, KitakyushuJapan

Personalised recommendations